Jeffrey M Leiden Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Jeffrey M Leiden has an estimated net worth of at least $71.0 million*, as of Dec. 18, 2024. They own 9,994 shares of VRTX stock. They have sold 209,982 shares of VRTX stock since 2021, for an estimated $66.3 million.
Jeffrey M Leiden $VRTX SEC Form 4 Insider Trading
Jeffrey M Leiden has filed a total of 25 insider trades in $VRTX since 2021. Their most recent trade was a sale of 3,784 shares, made on Aug 30, 2024. Their largest trade was a sale of 40,666 shares, made on Jul 25, 2022. We estimate that they now own 9,994 shares of $VRTX, worth an estimated $4.7 million.
Insider Trading at $VRTX
There have been a total of 474 insider trades reported at $VRTX since 2021, with 25,000 shares purchased and 808,928 shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Bastiano Sanna, and Ourania Tatsis. The most recent trade was a sale of 15 shares reported by DAVID ALTSHULER (EVP, Chief Scientific Officer), made on Nov 15, 2024.
History of Insider Stock Trades by Jeffrey M Leiden
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 3,784 | Aug 30, 2024 | Sept. 4, 2024, 4:13 p.m. |
|
VRTX
|
Sale | 4,655 | Feb 15, 2024 | Feb. 16, 2024, 5:07 p.m. |
|
VRTX
|
Sale | 4,356 | Feb 14, 2024 | Feb. 16, 2024, 5:07 p.m. |
|
VRTX
|
Sale | 737 | Feb 13, 2024 | Feb. 14, 2024, 5:04 p.m. |
|
VRTX
|
Sale | 647 | Feb 12, 2024 | Feb. 14, 2024, 5:04 p.m. |
|
VRTX
|
Sale | 2,009 | Feb 12, 2024 | Feb. 14, 2024, 5:04 p.m. |
|
VRTX
|
Sale | 6,648 | Jan 08, 2024 | Jan. 10, 2024, 5:06 p.m. |
|
VRTX
|
Sale | 13,254 | Dec 13, 2023 | Dec. 15, 2023, 5:33 p.m. |
|
VRTX
|
Sale | 100 | Dec 13, 2023 | Dec. 15, 2023, 5:33 p.m. |
|
VRTX
|
Sale | 12,962 | Oct 16, 2023 | Oct. 18, 2023, 4:17 p.m. |
|
VRTX
|
Sale | 708 | May 05, 2023 | May 9, 2023, 4:10 p.m. |
|
VRTX
|
Sale | 171 | May 05, 2023 | May 9, 2023, 4:10 p.m. |
|
VRTX
|
Sale | 1,125 | May 08, 2023 | May 9, 2023, 4:10 p.m. |
|
VRTX
|
Sale | 4,645 | May 02, 2023 | May 4, 2023, 4:50 p.m. |
|
VRTX
|
Sale | 1,800 | May 03, 2023 | May 4, 2023, 4:50 p.m. |
|
VRTX
|
Sale | 2,008 | May 03, 2023 | May 4, 2023, 4:50 p.m. |
|
VRTX
|
Sale | 300 | May 02, 2023 | May 4, 2023, 4:50 p.m. |
|
VRTX
|
Sale | 700 | May 03, 2023 | May 4, 2023, 4:50 p.m. |
|
VRTX
|
Sale | 1,505 | May 02, 2023 | May 4, 2023, 4:50 p.m. |
|
VRTX
|
Sale | 32,983 | Jul 25, 2022 | July 27, 2022, 4:17 p.m. |
|
VRTX
|
Sale | 13,869 | Jul 25, 2022 | July 27, 2022, 4:17 p.m. |
|
VRTX
|
Sale | 10,471 | Jul 25, 2022 | July 27, 2022, 4:17 p.m. |
|
VRTX
|
Sale | 40,666 | Jul 25, 2022 | July 27, 2022, 4:17 p.m. |
|
VRTX
|
Sale | 34,090 | Jul 25, 2022 | July 27, 2022, 4:17 p.m. |
|
VRTX
|
Sale | 15,789 | Apr 13, 2022 | April 14, 2022, 4:35 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Stuart A Arbuckle, EVP, COO
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Jeffrey M Leiden, Executive Chairman
-
Joy Liu, SVP, General Counsel
-
Reshma Kewalramani, CEO & President
-
Carmen Bozic, EVP and CMO
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Amit Sachdev, EVP, Chief Patient Officer
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.